Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Metastatic Castrate- Resistant Prostate Cancer × phenoxodiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Unspecified Adult Solid Tumor, Protocol Specific 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Neoplasms 1 Metastatic Castrate- Resistant Prostate Cancer 1

Interventions

phenoxodiol 1 Suppositories 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03041285 2022-05-11

Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate Cancer

Royal North Shore Hospital

Phase 1 Terminated

Metastatic Castrate- Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡